Strategic Advisory Board

Dr. Gregory Prince

D.D.S., Ph.D

Dr. Gregory Prince has received two doctorate degrees from UCLA, DDS in 1973 and PhD in pathology in 1975. He spent four decades in virus research, co-founding Virion Systems, Inc. and pioneering the prevention of RSV disease in premature infants using Synagis®, the first monoclonal antibody approved by the FDA for preventing any infectious disease.